Skip to content

TULSA-PRO System

by Profound Medical Inc. 4 variants

510(k) K230692

Active European Union and United States

CE MDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK230692 Date20 Sep 2023ClearedStatusActive
European UnionCE/MDD EUDAMED Number— Date—StatusActive

Official records

From the FDA record

Received by the FDA
13 Mar 2023
FDA decision
20 Sep 2023 (Substantially Equivalent)
FDA review time
191 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K230692 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Across registries

2 registries list this device

  • FDA 510(k) K230692 decided 20 Sep 2023 Active
  • EUDAMED Active

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k)

510(k) Number
FDA product code
PLP
FDA applicant
Profound Medical, Inc.
Device class
Class II
Regulation
21 CFR Part 876.4340
Advisory committee
Gastroenterology, Urology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The TULSA-Pro System is a High Intensity Focused Ultrasound (HIFU) device designed for prostate tissue ablation. It employs focused ultrasound energy to precisely target and treat benign prostatic hyperplasia (BPH) or localized prostate cancer by inducing thermal ablation without incisions or radiation.

This system is intended for use in urology and gastroenterology settings, supplied as a reusable medical device. It is not sterile upon delivery and requires appropriate preparation and maintenance as per manufacturer guidelines. The device is classified as Class II under FDA regulations and is authorized via 510(k) clearance, adhering to the Medical Device Directive (MDD) standards. Multiple registration numbers and FEI numbers are associated with its regulatory compliance.

Devices cleared under K230692

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K230692
UDI-DISize and differences
TULSA-PRO 112562
Profound Medical Inc
112562 / 11256207540281001721 —On the market

Similar devices

Other devices filed under FDA product code PLP (High Intensity Ultrasound System For Prostate Tissue Ablation).

Other devices from Profound Medical Inc.

  • Tulsa-Pro 105486

    Class II
  • Tulsa-Pro 104495

    Class II
  • Tulsa-Pro 103705

    Class II
  • Tulsa-Pro 109589

    Class II

See all devices from Profound Medical Inc. →